BeOne Medicines Ltd ADR (ONC): Next-Year EPS Estimate 45.41%
As of 2026-06-04, BeOne Medicines Ltd ADR (ONC) has a next-year EPS growth estimate of 45.41%.
On 2026-06-02, analyst consensus for ONC's next-year EPS growth shifted from 46.26% to 45.41% — a negative change of 0.85 percentage points. The revised estimate has been sustained across 3 subsequent trading sessions. Current-year growth is projected at 156.02%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 45.41%
- EPS growth this year
- 156.02%
- EPS next quarter (est)
- $1.65
- Last price
- $279.93
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 45.41% | 156.02% | $1.65 | $279.93 |
| 2026-06-03 | 45.41% | 156.02% | $1.65 | $279.00 |
| 2026-06-02 | 45.41% | 156.03% | $1.66 | $274.69 |
| 2026-06-01 | 46.26% | 150.13% | $1.56 | $279.68 |
| 2026-05-31 | 46.26% | 150.13% | $1.56 | $287.92 |
| 2026-05-28 | 46.26% | 150.13% | $1.56 | $290.58 |
| 2026-05-27 | 46.26% | 150.13% | $1.56 | $300.01 |
| 2026-05-26 | 46.26% | 150.13% | $1.56 | $302.44 |
| 2026-05-25 | 46.26% | 150.13% | $1.56 | $310.25 |
| 2026-05-24 | 45.60% | 149.66% | $1.56 | $310.25 |
| 2026-05-21 | 46.53% | 148.52% | $1.56 | $309.62 |
| 2026-05-20 | 46.53% | 148.52% | $1.56 | $308.74 |
| 2026-05-19 | 47.16% | 146.27% | $1.53 | $297.01 |
| 2026-05-18 | 47.16% | 146.27% | $1.53 | $293.09 |
| 2026-05-17 | 47.65% | 148.08% | $1.53 | $293.27 |
| 2026-05-14 | 47.62% | 148.03% | $1.53 | $304.62 |
| 2026-05-13 | 47.62% | 148.03% | $1.53 | $316.14 |
| 2026-05-12 | 47.62% | 148.03% | $1.53 | $315.07 |
| 2026-05-11 | 47.45% | 149.44% | $1.53 | $310.75 |
| 2026-05-10 | 49.17% | 143.55% | $1.53 | $312.12 |
| 2026-05-07 | 49.83% | 141.81% | $1.53 | $317.00 |
| 2026-05-06 | 55.76% | 135.38% | $1.20 | $313.32 |
| 2026-05-05 | 57.83% | 132.18% | $0.97 | $297.49 |
| 2026-05-04 | 57.83% | 132.18% | $0.97 | $297.14 |
| 2026-05-03 | 57.83% | 132.18% | $0.97 | $293.86 |
| 2026-04-30 | 57.83% | 132.18% | $0.97 | $295.27 |
| 2026-04-29 | 57.83% | 132.18% | $0.97 | $290.80 |
| 2026-04-28 | 57.83% | 132.18% | $0.97 | $298.16 |
| 2026-04-27 | 57.83% | 132.18% | $0.97 | $298.90 |
| 2026-04-26 | 57.29% | 133.13% | $1.01 | $300.80 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is BeOne Medicines Ltd ADR's next-year EPS growth estimate?▾
As of 2026-06-04, BeOne Medicines Ltd ADR (ONC) has a next-year EPS growth estimate of 45.41%, based on analyst consensus.
When was the latest EPS estimate revision for ONC?▾
The most recent revision occurred on 2026-06-02, when analysts adjusted the next-year EPS growth estimate from 46.26% to 45.41%.
What sector and industry does BeOne Medicines Ltd ADR belong to?▾
BeOne Medicines Ltd ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ONC appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. BeOne Medicines Ltd ADR (ONC) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports